There are countless aspects of the medical product production process that require attention. As industry capabilities, demands, and technology continue to evolve at a white-knuckle pace, particulate contamination reduction remains a critical area of focus for injectable products.
Yes, advances have begun to appear—Oliver included. We stand strong in our commitment to development of packaging products with particulate reduction features to meet rigorous ISO 11040-7 specifications. But the arena is so vast, it’s the proverbial tip of the iceberg. Whatever role your firm plays in the process, every individual effort exponentially elevates industry results.
We recently revisited this PDA Letter article discussing the benefits of a strong continuous improvement strategy in advancing industry’s zero particulates goal. With so many contributing factors, “zero” may seem like a utopian ideology, but author Chakraborty’s observations and recommendations are clear, appealing and actionable. What methods are you using to detect and reduce particulate?
